Abstract:Dietary fibre intake is negatively associated with stroke and overall mortality. A plausible hypothesis is that this happens via the gut microbiota, producing metabolites known as short-chain fatty acids (SCFAs) during fibre fermentation. Indeed, our unpublished data showed that low-fibre (LF) intake worsens stroke outcomes while high-fibre (HF) intake ameliorates it. Thus, we aimed to investigate whether switching from a LF diet pre-stroke to either a HF diet or supplementation with SCFAs post-stroke can improve functional and histological outcomes. We also aimed to determine if this effect is dependent on SCFAs-sensing G-protein coupled receptors GPR41, GPR43, and GPR109A. Male C57BL/6J mice (8–9 weeks, n = 8/group) were randomized and treated with a LF diet for 4-weeks prior to photothrombotic stroke surgery. Post-stroke, the mice were either fed with LF, HF or SCFAs for 7-days. Using MRI, we observed no difference in the infarct volume at day 1 (D1) post-stroke. However, a HF diet and SCFAs supplementation reduced infarct volume at day 7 (D7) (mean brain infarct volume ± SEM; LF:13.52 ± 2.43 mm3 vs HF:7.71 ± 1.12 mm3 vs SCFAs:5.25 ± 1.18 mm3, P = 0.007), and improved brain recovery rate (LF:64.93 ± 2.94% vs HF:78.06 ± 1.98% vs SCFAs:85.05 ± 2.45%, P < 0.001). High-fibre and SCFAs supplementation improved wire-hanging grip strength and coordination at D7, which measures motor function (mean % improvement ± SEM; LF:12.59 ± 2.66% vs HF:69.77 ± 8.44% vs SCFAs:97.42 ± 1.54%, P < 0.001). Immunofluorescence was performed to access gut barrier integrity, immune cell infiltration and neurogenesis in the brain at D7. HF and SCFAs improved gut barrier integrity (ZO-1, P < 0.001). Moreover, SCFAs-treated mice had fewer neutrophils (MPO+, P = 0.017) and more neuroblasts (DCX+/Tuj1+, P < 0.001) in the infarct core, with a positive correlation between DCX+/Tuj1+ and recovery rate post-stroke (R2 = 0.50, P < 0.001). To identify the receptors by which SCFAs improve stroke recovery, wild-type (WT) and GPR41/43/109a-/- mice (8–9 weeks, n = 8/group) were fed a HF diet pre- and post-stroke. GPR41/43/109a-/- mice showed worse stroke outcomes with larger brain infarct volume at D1 (P = 0.048) and D7 (P = 0.008), and worse recovery rate (P = 0.002). Consistent with this, wire-hanging grip strength was reduced (P < 0.001) at D7. In addition, compared to WT mice, GPR41/43/109a-/- mice had a leaky gut (P < 0.001), more neutrophils (P = 0.007) and very few neuroblasts (P = 0.011) in the infarct core. A high-fibre diet, resulting in the production of SCFAs, targets GPR41/43/109a signalling to reduce stroke-induced brain injury and improve functional recovery post-stroke. This improvement is likely to occur via neurogenesis and the suppression of the inflammatory response in the ischaemic brain.

Free Fatty Acids and Their Inflammatory Derivatives Affect BDNF in Stroke Patients

The Predictive Value of Serum F-actin on the Severity and Early Neurological Deterioration of Acute Ischemic Stroke: PREDICTIVE VALUE OF F-ACTIN IN STROKE

Free Fatty Acids Are Associated with the Cognitive Functions in Stroke Survivors

Association between Brain-Derived Neurotrophic Factor and Lipid Profiles in Acute Ischemic Stroke Patients

Elevated Serum and Cerebrospinal Fluid Free Fatty Acid Levels Are Associated with Unfavorable Functional Outcome in Subjects with Acute Ischemic Stroke

Fn-EDA (Fibronectin Containing Extra Domain A) in the Plasma, but Not Endothelial Cells, Exacerbates Stroke Outcome by Promoting Thrombo-Inflammation.

Effects of Brain-Derived Neurotrophic Factor on Local Inflammation in Experimental Stroke of Rat

Serum Free Fatty Acids Independently Predict Adverse Outcomes in Acute Heart Failure Patients

Low Plasma Proportion of Omega 3-Polyunsaturated Fatty Acids Predicts Poor Outcome in Acute Non-Cardiogenic Ischemic Stroke Patients

High-Serum Brain-Derived Neurotrophic Factor Levels Are Associated With Decreased Risk of Poststroke Cognitive Impairment

Dynamics of serum BDNF After Aerobic Exercise in Subacute Stroke Patients: A Sub-Analysis of the randomized controlled Phys-Stroke trial

Differential Association of Serum BDNF With Poststroke Depression and Poststroke Anxiety

S-44-4: POST-STROKE SUPPLEMENTATION WITH SHORT-CHAIN FATTY ACIDS ACCELERATES RECOVERY IN MICE VIA THE G-PROTEIN COUPLED RECEPTORS

Abstract TMP28: De Novo Fatty Acid Synthesis in Cd4 + T Cells after Cerebral Ischemic Stroke - A New Target of Post-stroke Immune Modulation

Predictive Value of Longitudinal Changes of Serum Matrix Metalloproteinase-9 and Brain-Derived Neurotrophic Factor in Acute Ischemic Stroke.

Abstract TMP109: Elovanoid Precursors Are Neuroprotective in Experimental Ischemic Stroke

Serum brain derived neurotrophic factor levels and post-stroke depression in ischemic stroke patients

Elevated Serum Levels of Brain-Derived Neurotrophic Factor and Mir-124 in Acute Ischemic Stroke Patients and the Molecular Mechanism

The association between circulating fatty acids and stroke in hypertensive patients

The Prognostic Biomarkers of Plasma Trimethylamine N-Oxide and Short-Chain Fatty Acids for Recanalization Therapy in Acute Ischemic Stroke

Relationship between ω3 and ω6 polyunsaturated fatty acids and atrial fibrillation in acute ischemic stroke